Phase 2 study of S-IROX as down staging chemotherapy for borderline resectable pancreatic cancer
Phase 2
Recruiting
- Conditions
- pancreatic cancer(borderline resectable)
- Registration Number
- JPRN-UMIN000033796
- Lead Sponsor
- Department of Hepatobiliary and Pancreatic Oncology/Surgery National Canser Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Not provided
Exclusion Criteria
History of treatment of other cancer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method R0 Resectability
- Secondary Outcome Measures
Name Time Method